Innospec [IOSP] vs Stepan Company [SCL] Detailed Stock Comparison
Innospec
NASDAQ
Loading...
Stepan Company
NYSE
Loading...
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Innospec wins in 8 metrics, Stepan Company wins in 12 metrics, with 0 ties. Stepan Company appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Innospec | Stepan Company | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 101.95 | 19.21 | Stepan Company |
| Price-to-Book Ratio | 1.51 | 0.89 | Stepan Company |
| Debt-to-Equity Ratio | 3.79 | 58.20 | Innospec |
| PEG Ratio | -4.11 | 1.01 | Innospec |
| EV/EBITDA | 29.71 | 8.89 | Stepan Company |
| Profit Margin (TTM) | 1.08% | 2.57% | Stepan Company |
| Operating Margin (TTM) | 7.96% | 3.06% | Innospec |
| EBITDA Margin (TTM) | 7.96% | 3.06% | Innospec |
| Return on Equity | 1.55% | 4.77% | Stepan Company |
| Return on Assets (TTM) | 0.53% | 2.05% | Stepan Company |
| Free Cash Flow (TTM) | $122.20M | $39.28M | Innospec |
| Dividend Yield | 1.97% | 2.13% | Stepan Company |
| 1-Year Return | -32.91% | -35.79% | Innospec |
| Price-to-Sales Ratio (TTM) | 1.09 | 0.49 | Stepan Company |
| Enterprise Value | $1.74B | $1.74B | Innospec |
| EV/Revenue Ratio | 0.97 | 0.77 | Stepan Company |
| Gross Profit Margin (TTM) | 28.02% | 12.09% | Innospec |
| Revenue per Share (TTM) | $72 | $99 | Stepan Company |
| Earnings per Share (Diluted) | $0.77 | $2.54 | Stepan Company |
| Beta (Stock Volatility) | 1.02 | 0.96 | Stepan Company |
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends
Innospec vs Stepan Company Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Innospec | -3.11% | -2.95% | -8.69% | -14.50% | -15.12% | -29.12% |
| Stepan Company | -1.93% | -1.35% | -1.35% | -19.35% | -3.14% | -23.82% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Innospec | -32.91% | -14.64% | 10.92% | 43.62% | 362.08% | 893.36% |
| Stepan Company | -35.79% | -49.18% | -58.16% | 4.49% | 52.84% | 305.13% |
News Based Sentiment: Innospec vs Stepan Company
Innospec
News based Sentiment: NEUTRAL
The announcement of an earnings release date is a standard practice and doesn't inherently signal positive or negative performance. It's a procedural update that sets the stage for a more substantial information release on November 4th and 5th, 2025, making it moderately important for investors to be aware of.
Stepan Company
News based Sentiment: POSITIVE
Stepan Company delivered strong Q2 results and provided a positive earnings outlook, leading to a stock price increase and reaffirming its commitment to shareholder returns through consistent dividend growth. While institutional selling is a factor, the overall narrative is positive, suggesting continued growth potential.
Performance & Financial Health Analysis: Innospec vs Stepan Company
| Metric | IOSP | SCL |
|---|---|---|
| Market Information | ||
| Market Cap | $1.97B | $1.11B |
| Market Cap Category | Small cap | Small cap |
| 10 Day Avg. Volume | 243,158 | 166,590 |
| 90 Day Avg. Volume | 217,616 | 190,690 |
| Last Close | $73.92 | $47.20 |
| 52 Week Range | $73.72 - $128.35 | $44.23 - $82.08 |
| % from 52W High | -42.41% | -42.50% |
| All-Time High | $133.71 (May 06, 2024) | $139.30 (May 10, 2021) |
| % from All-Time High | -44.72% | -66.12% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.01% | 0.07% |
| Quarterly Earnings Growth | -0.25% | 0.19% |
| Financial Health | ||
| Profit Margin (TTM) | 0.01% | 0.03% |
| Operating Margin (TTM) | 0.08% | 0.03% |
| Return on Equity (TTM) | 0.02% | 0.05% |
| Debt to Equity (MRQ) | 3.79 | 58.20 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $52.03 | $54.90 |
| Cash per Share (MRQ) | $10.74 | $3.93 |
| Operating Cash Flow (TTM) | $136.80M | $109.13M |
| Levered Free Cash Flow (TTM) | $-62,687,500 | $-18,496,500 |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.97% | 2.13% |
| Last 12-Month Dividend | $1.63 | $1.16 |
Valuation & Enterprise Metrics Analysis: Innospec vs Stepan Company
| Metric | IOSP | SCL |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 101.95 | 19.21 |
| Forward P/E | 12.54 | 11.99 |
| PEG Ratio | -4.11 | 1.01 |
| Price to Sales (TTM) | 1.09 | 0.49 |
| Price to Book (MRQ) | 1.51 | 0.89 |
| Market Capitalization | ||
| Market Capitalization | $1.97B | $1.11B |
| Enterprise Value | $1.74B | $1.74B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 0.97 | 0.77 |
| Enterprise to EBITDA | 29.71 | 8.89 |
| Risk & Other Metrics | ||
| Beta | 1.02 | 0.96 |
| Book Value per Share (MRQ) | $52.03 | $54.90 |
Financial Statements Comparison: Innospec vs Stepan Company
Financial Metrics
Loading Financial Charts...
Revenue
EBITDA
Operating Margin
Free Cash Flow
Long Term Debt
Profit Margin
Current Ratio
Operating Cash Flow
Income Statement (MRQ)
| Metric (MRQ) | IOSP | SCL |
|---|---|---|
| Revenue/Sales | $440.80M | $594.69M |
| Cost of Goods Sold | $315.70M | $522.80M |
| Gross Profit | $125.10M | $71.89M |
| Research & Development | $12.70M | $14.70M |
| Operating Income (EBIT) | $43.00M | $17.97M |
| EBITDA | $54.10M | $48.20M |
| Pre-Tax Income | $44.40M | $13.79M |
| Income Tax | $11.60M | $2.45M |
| Net Income (Profit) | $32.80M | $11.34M |
Balance Sheet & Liquidity Metrics (MRQ)
| Metric (MRQ) | IOSP | SCL |
|---|---|---|
| Cash & Equivalents | $299.80M | $88.90M |
| Total Current Assets | $977.10M | $914.77M |
| Total Current Liabilities | $357.60M | $677.83M |
| Long-Term Debt | $30.40M | $433.34M |
| Total Shareholders Equity | $1.27B | $1.24B |
| Retained Earnings | $1.06B | $1.29B |
| Property, Plant & Equipment | $321.50M | $2.77B |
Cash Flow Statement Comparison (MRQ)
| Metric (MRQ) | IOSP | SCL |
|---|---|---|
| Operating Cash Flow | $21.70M | $39.93M |
| Capital Expenditures | $100,000 | N/A |
| Free Cash Flow | $12.70M | $-14.41M |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | $-4.80M | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | IOSP | SCL |
|---|---|---|
| Shares Short | 334,515 | 398,886 |
| Short Ratio | 2.01 | 2.08 |
| Short % of Float | 0.02% | 0.03% |
| Average Daily Volume (10 Day) | 243,158 | 166,590 |
| Average Daily Volume (90 Day) | 217,616 | 190,690 |
| Shares Outstanding | 24.96M | 22.50M |
| Float Shares | 24.52M | 21.44M |
| % Held by Insiders | 0.01% | 0.05% |
| % Held by Institutions | 1.00% | 0.86% |
Dividend Analysis & Yield Comparison: Innospec vs Stepan Company
| Metric | IOSP | SCL |
|---|---|---|
| Last 12-Month Dividend | $1.63 | $1.16 |
| Last 12-Month Dividend Yield | 1.97% | 2.13% |
| 3-Year Avg Annual Dividend | $1.48 | $1.36 |
| 3-Year Avg Dividend Yield | 0.70% | 0.43% |
| 3-Year Total Dividends | $4.45 | $4.08 |
| Ex-Dividend Date | May 20, 2025 | Mar 03, 2025 |